Bill Maris

Bill Maris
Bill Maris is a venture capitalist and the CEO at GV, a venture capital firm established by Maris and funded through Alphabet. With approximately $2.4 billion under management and investments in Uber and Nest, the six-year-old fund is described as one of the hottest in Silicon Valley. Maris oversees all of GV’s funding activity and has a particular interest in next generation life sciences and artificial intelligence. He was instrumental in the formation of Google’s Calico project...
NationalityAmerican
ProfessionBusinessman
CountryUnited States of America
VC firms are... responsible for the full life cycle of a company: they find it, help it grow, open up a Rolodex, and sell it.
The reality is the technology exists now to extend life and have people live healthier, happier lives. Not to be kind of immortal - that's not what I'm talking about.
We actually have the tools in the life sciences to achieve anything that you have the audacity to envision. I just hope to live long enough not to die.
You make a great investment in the consumer Internet, maybe you make a lot of money and create something useful, interesting, or fun. But in life sciences, you have a chance to be part of something that lets people live longer and healthier and not lose the people they care about. That is really profound.
As life expectancy extends beyond 80 years in some parts of the world, more people are struggling with brain diseases. For older people, Alzheimer's, Parkinson's, and other conditions become a major impediment to quality of life.
I'm interested in the ideas that sound a little crazy, such as radical life extension, curing cancer, being able to create a simulation of the human brain and map every neuron.
I used to be a health-care investor a long time ago in the public markets. One thing I learned that we tried to apply here is that investing in small molecules, trying to invest in the next treatment, there's an element of gambling to that.
Say you have cancer - you have this broad thing we call cancer; we're going to irradiate you and pump this poisonous material into you and hope more of the bad stuff dies than the good. That is going to seem so medieval when we can fix it on a genetic level, and Foundation Medicine is the first step to diagnosing it on a genetic level.
People talk about the redistribution of wealth a lot, which is a very valid topic. But what about the redistribution of health? That's even more concentrated at the top.
We have this powerful lever at Google Ventures, which is to invest $200 million a year. This is a huge lever. It's not all going into one place; it's going into lots of start ups and founders and entrepreneurs, all of which are levers to try and change the world in one way or another.
I would draw a really big distinction between competition, or potential competition, and a conflict of interest. A conflict of interest implies wrongdoing, whereas competition is really healthy.
There are a number of start-ups in Europe that are able to reach beyond their own country. Take Spotify - Spotify just in Sweden isn't that interesting compared to Spotify all over the world.
We're looking for people who are working on things that seem out of reach, uncomfortably difficult.
We make a series of investments, some will pan out and some won't.